Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors

An involvement of the transient receptor potential vanilloid (TRPV) 1 channel in the regulation of body temperature (T b) has not been established decisively. To provide decisive evidence for such an involvement and determine its mechanisms were the aims of the present study. We synthesized a new TRPV1 antagonist, AMG0347 [(E)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1- yl)-3-(2-(piperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)acrylamide], and characterized it in vitro. We then found that this drug is the most potent TRPV1 antagonist known to increase T b of rats and mice and showed (by using knock-out mice) that the entire hyperthermic effect of AMG0347 is TRPV1 dependent. AMG0347-induced hyperthermia was brought about by one or both of the two major autonomic cold-defense effector mechanisms (tail-skin vasoconstriction and/or thermogenesis), but it did not involve warmth-seeking behavior. The magnitude of the hyperthermic response depended on neither T b nor tail-skin temperature at the time of AMG0347 administration, thus indicating that AMG0347-induced hyperthermia results from blockade of tonic TRPV1 activation by nonthermal factors. AMG0347 was no more effective in causing hyperthermia when administered into the brain (intracerebroventricularly) or spinal cord (intrathecally) than when given systemically (intravenously), which indicates a peripheral site of action. We then established that localized intra-abdominal desensitization of TRPV1 channels with intraperitoneal resiniferatoxin blocks the T b response to systemic AMG0347; the extent of desensitization was determined by using a comprehensive battery of functional tests. We conclude that tonic activation of TRPV1 channels in the abdominal viscera by yet unidentified nonthermal factors inhibits skin vasoconstriction and thermogenesis, thus having a suppressive effect on T b. Copyright © 2007 Society for Neuroscience.

Anestesia para colecistectomía videolaparoscópica en paciente portador de enfermedad de Steinert. Relato de caso y revisiõn de la literatura

BACKGROUND AND OBJECTIVES: Myotonic dystrophies are autosomal dominant neuromuscular diseases. Among them, myotonic dystrophy type 1 (MD1), or Steinert disease, is the most common in adults, and besides muscular involvement it also has important systemic manifestations. Myotonic dystrophy type 1 poses a challenge to the anesthesiologist. Those patients are more sensitive to anesthetics and prone to cardiac and pulmonary complications. Besides, the possibility of developing malignant hyperthermia and myotonic episodes is also present. CASE REPORT: This is a 39-year old patient with DM1 who underwent general anesthesia for videolaparoscopic cholecystectomy. Total intravenous anesthesia with propofol, remifentanil, and rocuronium was the technique chosen. Intercurrences were not observed in the 90-minute surgical procedure, but after extubation, the patient developed respiratory failure and myotonia, which made tracheal intubation impossible. A laryngeal mask was used, allowing adequate oxygenation, and mechanical ventilation was maintained until full recovery of the respiratory function. The patient did not develop further complications. CONCLUSIONS: Myotonic dystrophy type 1 presents several particularities to the anesthesiologist. Detailed knowledge of its systemic involvement along with the differentiated action of anesthetic drugs in those patients will provide safer anesthetic-surgical procedure.

Advances in drug design based on the amino acid approach: Taurine analogues for the treatment of CNS diseases

Amino acids are well known to be an important class of compounds for the maintenance of body homeostasis and their deficit, even for the polar neuroactive aminoacids, can be controlled by supplementation. However, for the amino acid taurine (2-aminoethanesulfonic acid) this is not true. Due its special physicochemical properties, taurine is unable to cross the blood-brain barrier. In addition of injured taurine transport systems under pathological conditions, CNS supplementation of taurine is almost null. Taurine is a potent antioxidant and anti-inflammatory semi-essential amino acid extensively involved in neurological activities, acting as neurotrophic factor, binding to GABA A/glycine receptors and blocking the excitotoxicity glutamate-induced pathway leading to be a neuroprotective effect and neuromodulation. Taurine deficits have been implicated in several CNS diseases, such as Alzheimer's, Parkinson's, epilepsy and in the damage of retinal neurons. This review describes the CNS physiological functions of taurine and the development of new derivatives based on its structure useful in CNS disease treatment.&; 2012 by the authors; licensee MDPI, Basel, Switzerland.

Análise químico-farmacêutica de azumoleno sódico

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Estudo da ação de nanopartículas magnéticas de ferro no câncer oral

Pós-graduação em Genética - IBILCE

Aspectos da infecção toxoplasmática no sistema reprodutor de ovinos (Ovis aries) machos experimentalmente infectados

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Efeitos da termoterapia induzida pela água na próstata: estudo experimental em cães

Pós-graduação em Bases Gerais da Cirurgia - FMB

Infecção experimental com Salmonella Dublin em bezerros bubalinos: estudo clínico, laboratorial e terapêutico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Síntese e funcionalização de superfícies de óxido de ferro superparamagnéticos

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Alterações clínicas, hematológicas, bioquímicas e histopatológicas em ovinos infectados experimentalmente por Trypanosoma vivax (Ziemann, 1905)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Transmissão congênita de toxoplasma gondii (Nicolle & Manceaux, 1909), em cabras experimentalmente reinfectadas

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Effects of Thermal Stress on Hepatic Melanomacrophages of Eupemphix nattereri (Anura)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Prevalência de equinos quarto de milha portadores das mutações causadoras da miopatia por acúmulo de polissacarídeo tipo 1, paralisia periódica hipercalêmica e hipertermia maligna no Brasil

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Regulação da temperatura corporal em diferentes estados térmicos: ênfase na anapirexia

Temperature is certainly one of the major factors that affect biochemical and physiological processes. So, the investigation of how animals regulate body temperature (Tb) and respond to changes in ambient temperature is indispensable. There are five thermal states defined up to date that include euthermy, hypo and hyperthermia (forced fall and increase of Tb, respectively), fever and anapyrexia (regulated increase and fall of Tb, respectively). In this review, we present some classic and recent data about thermoregulatory mechanisms involved in those thermal states with special attention directed to anapyrexia, a phenomenon that has attracted the interest of researchers due to its potential therapeutic benefits.

TRPV4 activates autonomic and behavioural warmth-defence responses in Wistar rats

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)